Skip to main content

INSIGHTS AND PERSPECTIVES

  • Study: Obesity trumps smoking when it comes to impact on long-term healthcare costs

    PHILADELPHIA — Obesity adds more to healthcare costs than smoking does, according to a study published in the March Journal of Occupational and Environmental Medicine, the official publication of the American College of Occupational and Environmental Medicine.

  • Spending on branded, generic drugs increased in 2011, IMS report finds

    PARSIPPANY, N.J. — People ages 65 years and older reduced their volume of prescriptions, while those ages 19 to 25 years increased their use of prescription drugs as the healthcare-reform law allowed them to remain on their parents' insurance, according to a new report by IMS Health.

    The report, "The Use of Medicines in the United States: Review of 2011," found that per capita spending on U.S. medicines grew by 0.5% as healthcare system spending reached $320 billion and new drug launches opened new treatment options for more than 20 million Americans.

  • Walgreens immunization studies: Pharmacy instrumental in helping states combat disease

    DEERFIELD, Ill. — Walgreens on Tuesday released case studies presented last week before the Centers for Disease Control and Prevention's 2012 National Immunization Conference on how retail pharmacy can expand access to immunizations and help support disease-prevention initiatives.

    The studies demonstrated the impact of three Walgreens initiatives aimed at increasing immunization rates: off-clinic hour vaccine administration, a pharmacist-led meningitis vaccination program and expansion of access to immunization services in underserved areas.

  • CDC report: Some ethnic groups need to boost vitamin D, iron supplementation

    ATLANTA — Overall, the U.S. population has good levels of vitamin A and folate in the body, but some groups still need to increase their levels of vitamin D and iron, according to the "Second National Report on Biochemical Indicators of Diet and Nutrition," released Monday by the Centers for Disease Control and Prevention.

  • Astellas, Vical finalize design for phase-3 cytomegalovirus vaccine trial

    SAN DIEGO — Two drug makers have finalized the design of a late-stage clinical trial for a vaccine against a common virus that can cause complications later in life.

    Vical and Astellas Pharma announced Monday that they had finalized the general design of a phase-3 trial of TransVax, a vaccine against cytomegalovirus, or CMV, for transplant recipients.

  • Metformin may help slow progression, reduce risk of certain cancers

    NEW YORK — A medication commonly prescribed for patients with Type 2 diabetes also may play a critical role in patients at risk of developing certain cancers.

    In three separate studies published in Cancer Prevention Research, a journal of the American Association for Cancer Research, findings showed how metformin may protect against oral cancer and liver cancer, as well as slow the growth rate of prostate cancer among men prior to prostatectomy.

  • Report: Cancer death rates continue to decline

    ATLANTA — Mortality rates from all cancers combined continued to drop between 2004 and 2008 among men, women and children, according to the annual "Report to the Nation on the Status of Cancer, 1975-2008."

  • Competition really heating up in Canada

    WHAT IT MEANS AND WHY IT'S IMPORTANT — The news that Target has revealed the locations of its first 12 stores in Quebec is just one more reminder that the competition in Canada is really going to heat up.

    (THE NEWS: Target confirms locations of 12 Quebec debut stores. For the full story, click here)

X
This ad will auto-close in 10 seconds